Topics

ENBREL Company Profile

17:13 EST 28th January 2020 | BioPortfolio

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in their bodies. ENBREL can reduce the amount of TNF in the body to normal levels, helping to treat your disease. But, in doing so, ENBREL can also lower the ability of your immune system to fight infections.All medicines have side effects, including ENBREL. Possible side effects of ENBREL include:Serious infections
Many occurred in people prone to infection, such as those with advanced or poorly controlled diabetes Some serious infections have been fatal

Location

Thousand Oaks
California
91320
United States of America

Contact

Email: webcoordinator@amgen.com


News Articles [49 Associated News Articles listed on BioPortfolio]

Court sides with Amgen in Sandoz' challenge over patent on Enbrel

A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel. US District Judge Claire Cecchi in Newark, New Jersey, upheld two patents on Amgen’...

Amgen wins Enbrel patent protections — for now

Amgen has fought off a patent challenge from Novartis to its blockbuster anti-inflammatory, Enbrel.

Sandoz to Appeal Ruling that Upholds Patents on Amgen’s Enbrel

Sandoz' biosimilar to Enbrel was approved in 2016 by the FDA but has remained off the market due to the patent protection surrounding Amgen's blockbuster rheumatoid arthritis treatment.

Amgen Wins Enbrel Patent Case

The US District Court for the District of New Jersey has upheld two of Amgen’s patents for its top-selling drug Enbrel (etanercept) in a ruling against Sandoz, which has been seeking to launch i...

Court sides with Amgen in Enbrel biosimilar patent case

The US District Court for the District of New Jersey ruled in Amgenâs favor on the validity of the two patents on Enbrel and the methods for making it.

Novartis unterliegt Amgen im Patentstreit um Blockbuster Enbrel

New York (awp/sda/reu) - Im Streit zwischen Novartis und Amgen über den Patentschutz für dessen Blockbuster-Medikament Enbrel haben die Schweizer eine Niederlage erlitten. US-Bundesbezirksrichterin....

Abarca, Amgen push the envelope with outcomes-based plan for Enbrel

Health plans should be more willing to pay for high-cost drugs if they actually produce the results patients expect: cures, symptom relief, etc. But pay-for-outcome deals are few and far between. Abar...

U.S. court upholds Amgen patents on arthritis drug Enbrel

A U.S. judge on Friday said patents relating to the Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a challenge by Novartis AG, which is seeking to launch a copycat versio...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Enbrel [a-s medication solutions]

These highlights do not include all the information needed to use ENBREL safely and effectively. See full prescribing information for ENBREL .     ENBREL (etanercept)   injection , for subcutaneou...

Enbrel [immunex corporation]

These highlights do not include all the information needed to use ENBREL safely and effectively. See full prescribing information for ENBREL .     ENBREL (etanercept)   injection , for subcutaneou...

PubMed Articles [0 Results]

None

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis

The purpose of this study is to evaluate the use of Enbrel® (etanercept) in the treatment of psoriasis in patients for a period of up to 1 year.

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

To investigate the changes in MRI-derived markers of joint inflammation and destruction and in biochemical markers of connective tissue metabolism and angiogenesis in rheumatoid arthritis ...

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

The special use-results surveillance is conducted in patients who have never been treated with Enbrel and in whom its long-term therapy may be instituted in the actual setting of use after...

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

The purpose of this study is to investigate the incidence of adverse events for patients with rheumatoid arthritis treated with Enbrel under usual care settings. In addition, differences ...

Prospective Evaluation of the Radiographic Efficacy of Enbrel

It is known from the COMET-trial that patients who start Enbrel treatment early have a great chance of reaching clinical remission and radiographic nonprogression. It is still unclear, how...

Companies [3 Associated Companies listed on BioPortfolio]

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheuma...

Enbrel® (etanercept)

Enbrel® (etanercept) is a TNF inhibitor approved for the following indications: moderately to severely active rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, psoriatic arthr...

VLST Corp

VLST Corporation discovers and develops novel therapeutics for the treatment of inflammatory and autoimmune diseases. Disease areas in which the company’s technology may have utility include multip...

More Information about "ENBREL" on BioPortfolio

We have published hundreds of ENBREL news stories on BioPortfolio along with dozens of ENBREL Clinical Trials and PubMed Articles about ENBREL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ENBREL Companies in our database. You can also find out about relevant ENBREL Drugs and Medications on this site too.

Quick Search

Relevant Topic

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...


Corporate Database Quicklinks



Searches Linking to this Company Record